Earnings per share for the last twelve months: CG Oncology Inc (CGON)

CG Oncology (CGON) - corporate logo

High R&D expenditures are creating financial pressure, as confirmed by the current level of rolling earnings per share; the value of -2.75 reflects this status. CG Oncology, Inc. (CGON) retains top scientists through grants and stock options. The development of bladder cancer immunotherapy relies on partnerships with clinics. A revenue deficit is forcing the company to utilize reserves and raise external capital.

CGON (CG Oncology Therapeutics) Net earnings per one share for the last twelve months history from 02/21/2024 to 11/18/2026

Analytical breakdowns for CG Oncology, Inc.

- share price and expert price forecast:
- company stock exchange capitalization indicators:
General company analysis:CGON - CG Oncology Therapeutics
Manufactured products of CG Oncology Therapeutics

CG Oncology, Inc. (CGON) is focusing on building a commercial foundation under the leadership of experienced managers who have earned market trust following successful clinical trials. Analyzing the rolling 12-month EPS allows for the tracking of per-share income, stripped of the influence of share count and seasonality, which helps investors timely identify qualitative changes in the business's fundamental state and risks of margin compression.

Main competitors

ONC - Earnings per share for the last twelve months|HALO - Net earnings per share (EPS TTM)|RevMed (RVMD) - Earnings per share for the last twelve months|Ascentage - Earnings per share for the trailing year|URGN (UroGen Pharma Ltd) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bicara Therapeutics Inc. BCAX|Earnings per share for the last twelve months Personalis, Inc. (PSNL)|ERAS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) DCTH (delcath.com)|Net earnings per share for the trailing year Y-mAbs Corp|AURA - Earnings per share for the last twelve months|CADL (candeltx.com) - Earnings per share for the last 12 months|ARAY (accuray.com) - Net earnings per share for the last 12 months|SELLAS Life Sciences Group Inc. (SLS) - Net earnings per share (EPS TTM)|ACTU (Actuate Therapeutics Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Citius Oncology Inc|Net earnings per share (EPS TTM) HURA|TARA (Protara Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) FATE (Fate Therapeutics)|Net earnings per share for the last four quarters Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Net earnings per share (EPS TTM)|CSBR (Champions Oncology, Inc.) - Earnings per share for the last 12 months|XBIT (XBiotech USA) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Radiopharm Theranostics (RADX)|Net earnings per share for the last 12 months ARTV (Artiva Biotherapeutics, Inc.)|ANL - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Veru Inc. VERU|Earnings per share for the trailing year TPST|XLO: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Renovaro RENB|MURA (muraloncology.com) - Net earnings per share for the last 12 months|Kairos Pharma Inc - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKUR|Net earnings per one share for the last twelve months CytoMed Therapeutics Limited GDTC|Net earnings per share (EPS TTM) CRIS|Net earnings per share (EPS TTM) Apollomics Inc. (APLM)|Net earnings per share (EPS TTM) THAR (Tharimmune Corp)|Net earnings per share for the last four quarters Advanced Biomed Inc (ADVB)|Genprex Inc - Net earnings per share (EPS TTM)|CLDI - Net earnings per share (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Earnings per share for the last twelve months|XBIO - Net earnings per share for the last four quarters|SLRX (Salarius Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Kitov Pharma|Net earnings per share for the last 12 months AONC (American Oncology Network)|BGNE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Earnings per share for the last twelve months|ICAD - Earnings per share for the last twelve months|IKNA - Net earnings per share (EPS TTM)|Notable Labs (NTBL) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VIRX|MOR (MorphoSys Corporation) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NAYA Biosciences Inc NAYA|Earnings per share for the last twelve months Ascentage Pharma (AAPGV)